EcoDrugPlus

Glutamate Receptor Ionotropic, Nmda 2d-Like

Ensembl ID : ENSPREG00000000885
Gene Symbol: LOC103472853
2 Cross references
214 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 3b-Like

Ensembl ID : ENSPREG00000012869
Gene Symbol: LOC103458409
2 Cross references
226 Possible Orthologues:

Glutamate Receptor, Ionotropic, Ampa 4b

Ensembl ID : ENSPREG00000016137
Gene Symbol: GRIA4B
1 Cross references
248 Possible Orthologues:

Glutaminase Kidney Isoform, Mitochondrial

Ensembl ID : ENSPREG00000021334
Gene Symbol: LOC103457187
3 Cross references
228 Possible Orthologues:

Glutaminase Kidney Isoform, Mitochondrial-Like

Ensembl ID : ENSPREG00000001236
Gene Symbol: LOC103461842
2 Cross references
230 Possible Orthologues:

Glycogen Synthase Kinase 3 Alpha

Ensembl ID : ENSPREG00000013855
Gene Symbol: GSK3A
3 Cross references
186 Possible Orthologues:

Glycogen Synthase Kinase 3 Beta

Ensembl ID : ENSPREG00000000763
Gene Symbol: GSK3B
3 Cross references
222 Possible Orthologues:

Glycogen Synthase Kinase-3 Beta-Like

Ensembl ID : ENSPREG00000007073
Gene Symbol: LOC103472964
3 Cross references
187 Possible Orthologues:

Granzyme G-Like

Ensembl ID : ENSPREG00000007406
Gene Symbol: LOC103463689
2 Cross references
963 Possible Orthologues:

Granzyme-Like Protein 1

Ensembl ID : ENSPREG00000007425
Gene Symbol: LOC103463688
2 Cross references
961 Possible Orthologues:

Growth Hormone Releasing Hormone Receptor

Ensembl ID : ENSPREG00000010762
Gene Symbol: GHRHR
4 Cross references
191 Possible Orthologues:

Growth Hormone Secretagogue Receptor Type 1-Like

Ensembl ID : ENSPREG00000012316
Gene Symbol: LOC103458418
3 Cross references
212 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).